The Sleep Testing Services Market, estimated at USD 9.94 Bn in 2025, is expected to exhibit a CAGR of 12.1% and reach USD 22.11 Bn by 2032.
The market growth is driven by rising demand for accurate and early disease detection, supported by advances in molecular diagnostics, imaging, and point-of-care testing. Growing focus on personalized medicine, supportive healthcare policies, and ongoing R&D investments are creating new opportunities for industry players.
Global sleep testing services provide comprehensive solutions for diagnosing and managing sleep disorders worldwide. They conduct sleep studies, monitor physiological activities during sleep, and employ advanced technology and equipment for accurate results. Sleep specialists work closely with patients to develop personalized treatment plans. These services aim to raise awareness, promote research, and improve sleep health globally.
Global Sleep Testing Services Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding transportation of drugs from one place to another.
COVID-19 pandemic has had a significant impact on the sleep testing services market. Lockdowns and restrictions led to the temporary closure or reduced operations of sleep testing facilities, resulting in a decline in tests conducted. Home sleep testing gained popularity as a safer alternative, allowing patients to conduct tests at home. Delayed diagnosis and treatment occurred due to limited access to healthcare facilities. Telemedicine played a crucial role in providing virtual consultations and follow-up care. As vaccination efforts progress and restrictions ease, the market is expected to recover gradually with safety measures in place.
In March 2025, a survey conducted by Medqor highlighted a notable decline in patient visits to sleep centers, with approximately 68.0% of the participants reporting this decrease. The outbreak of the pandemic was identified as the primary factor contributing to this decline in patient visits.
Global Sleep Testing Services Market: Key Developments
In December 2025, the sleep clinic at Clark Memorial Health which is located in Jeffersonville in USA. Clark Memorial Health received approval from the Accreditation Commission for Health Care (ACHC) to provide sleep treatment services in the Indiana region.
In October 2025, Resmed Inc., ResMed Inc. is a global leader in digital health and sleep apnea treatment, providing innovative solutions and medical devices to improve the lives of individuals with sleep-related disorders. With a focus on advancing digital health technologies, ResMed is committed to transforming care and empowering patients to manage their conditions effectively. which initially held a minor investment in Ectosense (Ectosense is a company that specializes in sleep diagnostics and therapy solutions. They offer innovative products and technologies for the diagnosis and management of sleep disorders), completed the acquisition of the company. This acquisition allows Resmed Inc. to expand its consumer database in countries such as New Zealand, Australia, the U.S., EU territories, and India. Ectosense will now operate within ResMed Inc.'s Sleep and Respiratory Care business.